Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does MIDOMAFETAMINE Cause Hypoxic-ischaemic encephalopathy? 6 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Hypoxic-ischaemic encephalopathy have been filed in association with MIDOMAFETAMINE. This represents 0.4% of all adverse event reports for MIDOMAFETAMINE.

6
Reports of Hypoxic-ischaemic encephalopathy with MIDOMAFETAMINE
0.4%
of all MIDOMAFETAMINE reports
4
Deaths
4
Hospitalizations

How Dangerous Is Hypoxic-ischaemic encephalopathy From MIDOMAFETAMINE?

Of the 6 reports, 4 (66.7%) resulted in death, 4 (66.7%) required hospitalization, and 2 (33.3%) were considered life-threatening.

Is Hypoxic-ischaemic encephalopathy Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for MIDOMAFETAMINE. However, 6 reports have been filed with the FAERS database.

What Other Side Effects Does MIDOMAFETAMINE Cause?

Drug abuse (608) Toxicity to various agents (262) Coma (146) Substance abuse (140) Intentional product misuse (126) Drug dependence (116) Somnolence (111) Agitation (104) Substance use disorder (104) Drug use disorder (103)

What Other Drugs Cause Hypoxic-ischaemic encephalopathy?

MORPHINE (72) METHADONE (69) OXYCODONE (69) GABAPENTIN (65) FENTANYL (61) ACETAMINOPHEN (58) DIAZEPAM (55) ONDANSETRON (48) TRAMADOL (48) METFORMIN (45)

Which MIDOMAFETAMINE Alternatives Have Lower Hypoxic-ischaemic encephalopathy Risk?

MIDOMAFETAMINE vs MIDOSTAURIN MIDOMAFETAMINE vs MIFEPRISTONE MIDOMAFETAMINE vs MIGALASTAT MIDOMAFETAMINE vs MIGLITOL MIDOMAFETAMINE vs MIGLUSTAT

Related Pages

MIDOMAFETAMINE Full Profile All Hypoxic-ischaemic encephalopathy Reports All Drugs Causing Hypoxic-ischaemic encephalopathy MIDOMAFETAMINE Demographics